– the leading provider of online annual reports to individual and institutional investors.

Generex Biotechnology Corp.

Generex Biotechnology Corporation, a development stage company, engages in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases. It develops a proprietary platform technology for the oral administration of large molecule drugs, including proteins, peptides, monoclonal antibodies, hormones, and vaccines.

No responsibility reports added yet

Browse Reports